| Literature DB >> 28150064 |
Sanjay Divakaran1, Avinainder Singh2, Bradley Collins2,3, Tomas Vita2, Rodney H Falk1, Marcelo F Di Carli1,2, Ron Blankstein4,5.
Abstract
OPINION STATEMENT: Infiltrative heart disease is caused by the deposition of abnormal substances in the heart and can lead to abnormalities in cardiac function and electrical conduction. Advances in non-invasive cardiovascular imaging have allowed for improved diagnosis of infiltrative heart disease, as well as ways to track disease progression or regression, thus enabling a mechanism to follow response to therapy. In this review, we provide an overview of the role of imaging in the diagnosis and management of cardiac sarcoidosis (CS) and cardiac amyloidosis (CA), as well as outline a proposed algorithm for using non-invasive cardiovascular imaging for evaluating these conditions.Entities:
Keywords: Cardiac amyloidosis; Cardiovascular imaging; Imaging; Infiltrative heart disease
Year: 2017 PMID: 28150064 PMCID: PMC5460755 DOI: 10.1007/s11936-017-0500-3
Source DB: PubMed Journal: Curr Treat Options Cardiovasc Med ISSN: 1092-8464